Compare $BBNX vs $PRCT | Chartloom

Compare

$BBNX vs $PRCT

Beta Bionics Inc · Procept Biorobotics Corp

BBNX

Beta Bionics Inc

PRCT

Procept Biorobotics Corp

Compare $BBNX vs $PRCT

Comparing Beta Bionics Inc and Procept Biorobotics Corp

BBNXBeta Bionics Inc

PRCTProcept Biorobotics Corp

BBNXBeta Bionics Inc

Market cap

$793M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.37x

Rev growth (TTM)

94.1%

YTD performance

-39.7%

52W performance

-20.3%

FCF yield

-7.7%

PRCTProcept Biorobotics Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.35x

Rev growth (TTM)

22.7%

YTD performance

-40.2%

52W performance

-47.1%

FCF yield

-8.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BBNX

PRCT

Detailed metrics comparison

BBNX

Beta Bionics Inc

PRCT

Procept Biorobotics Corp

Market Cap

BBNX$793M

PRCT$1.05B

Enterprise Value

BBNX$749M

PRCT$871M

Price

BBNX$17.63

PRCT$18.40

P/E Ratio

BBNXN/A

PRCTN/A

P/S Ratio

BBNX6.66x

PRCT3.10x

EV/Sales

BBNX6.29x

PRCT2.58x

EV/EBITDA

BBNX0.00x

PRCT0.00x

P/B Ratio

BBNX3.99x

PRCT2.89x

P/FCF Ratio

BBNXN/A

PRCTN/A

EV/FCF

BBNX-12.19x

PRCT-10.26x

PEG Ratio

BBNXN/A

PRCTN/A

Forward P/E (NTM)

BBNXN/A

PRCTN/A

Forward P/S (NTM)

BBNX5.37x

PRCT2.35x

Revenue (TTM)

BBNX$119M

PRCT$337M

Revenue Growth (YoY)

BBNX94.1%

PRCT22.7%

Forward Rev Growth

BBNX34.2%

PRCT20.6%

Gross Margin (TTM)

BBNX58.3%

PRCT64.2%

Operating Margin (TTM)

BBNX0.0%

PRCT0.0%

EBITDA Margin (TTM)

BBNX-67.9%

PRCT-31.8%

Net Margin (TTM)

BBNX-61.3%

PRCT-32.5%

FCF Margin (TTM)

BBNX-51.6%

PRCT-25.2%

Net Income (TTM)

BBNX$-73M

PRCT$-110M

FCF (TTM)

BBNX$-61M

PRCT$-85M

EPS (TTM)

BBNX-$1.64

PRCT-$1.92

ROE (TTM)

BBNX-2630.0%

PRCT-3062.0%

ROA (TTM)

BBNX-2325.0%

PRCT-2211.0%

ROIC (TTM)

BBNX-2630.0%

PRCT-2676.0%

Cash

BBNX$44M

PRCT$228M

Debt

BBNX$0

PRCT$52M

Net Cash/Debt

BBNX$44M

PRCT$176M

Current Ratio (TTM)

BBNX8.88x

PRCT6.55x

Quick Ratio (TTM)

BBNX7.72x

PRCT5.23x

Debt/Equity (TTM)

BBNX0.00x

PRCT0.15x

Debt/Assets (TTM)

BBNX0.0%

PRCT0.0%

Interest Coverage (TTM)

BBNXN/A

PRCTN/A

Net Debt/EBITDA (TTM)

BBNX0.00x

PRCT0.00x

Beta

BBNX0.92

PRCT0.88

52W Performance

BBNX-20.3%

PRCT-47.1%

YTD Performance

BBNX-39.7%

PRCT-40.2%

% from 52W High

BBNX-46.1%

PRCT-51.7%

% from 52W Low

BBNX100.3%

PRCT10.4%

Asset Turnover (TTM)

BBNX0.38x

PRCT0.68x

FCF Yield (TTM)

BBNX-7.7%

PRCT-8.1%

Earnings Yield (TTM)

BBNX-9.2%

PRCT-10.5%

Dividend Yield (TTM)

BBNXN/A

PRCTN/A

Rule of 40

BBNX42.5

PRCT-2.5

EV/GP/RG

BBNX0.34

PRCT0.12

Ticker research

View BBNX research View PRCT research

Metric	BBNX Beta Bionics Inc	PRCT Procept Biorobotics Corp
Market & Valuation
Market Cap	$793M	$1.05B
Enterprise Value	$749M	$871M
Price	$17.63	$18.40
P/E Ratio	N/A	N/A
P/S Ratio	6.66x	3.10x
EV/Sales	6.29x	2.58x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.99x	2.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.19x	-10.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.37x	2.35x
Revenue & Growth
Revenue (TTM)	$119M	$337M
Revenue Growth (YoY)	94.1%	22.7%
Forward Rev Growth	34.2%	20.6%
Profitability
Gross Margin (TTM)	58.3%	64.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-67.9%	-31.8%
Net Margin (TTM)	-61.3%	-32.5%
FCF Margin (TTM)	-51.6%	-25.2%
Net Income (TTM)	$-73M	$-110M
FCF (TTM)	$-61M	$-85M
EPS (TTM)	-$1.64	-$1.92
ROE (TTM)	-2630.0%	-3062.0%
ROA (TTM)	-2325.0%	-2211.0%
ROIC (TTM)	-2630.0%	-2676.0%
Financial Health
Cash	$44M	$228M
Debt	$0	$52M
Net Cash/Debt	$44M	$176M
Current Ratio (TTM)	8.88x	6.55x
Quick Ratio (TTM)	7.72x	5.23x
Debt/Equity (TTM)	0.00x	0.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	0.88
52W Performance	-20.3%	-47.1%
YTD Performance	-39.7%	-40.2%
% from 52W High	-46.1%	-51.7%
% from 52W Low	100.3%	10.4%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.68x
FCF Yield (TTM)	-7.7%	-8.1%
Earnings Yield (TTM)	-9.2%	-10.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.5	-2.5
EV/GP/RG	0.34	0.12
Ticker research	View BBNX research	View PRCT research

Valuation

P/S Ratio

PRCT

3.10x

BBNX

6.66x

EV/FCF

BBNX

-12.19x

PRCT

-10.26x

Growth & revenue

Revenue Growth TTM

BBNX

94.1%

PRCT

22.7%

Forward Revenue Growth

BBNX

34.2%

PRCT

20.6%

Profitability & performance

Gross Margin

PRCT

64.2%

BBNX

58.3%

ROE

BBNX

-2630.0%

PRCT

-3062.0%

FCF Yield %

BBNX

-7.7%

PRCT

-8.1%

52-Week Performance

BBNX

-20.3%

PRCT

-47.1%

Detailed metrics comparison

BBNX

Beta Bionics Inc

PRCT

Procept Biorobotics Corp

Market Cap

BBNX$793M

PRCT$1.05B

Enterprise Value

BBNX$749M

PRCT$871M

Price

BBNX$17.63

PRCT$18.40

P/E Ratio

BBNXN/A

PRCTN/A

P/S Ratio

BBNX6.66x

PRCT3.10x

EV/Sales

BBNX6.29x

PRCT2.58x

EV/EBITDA

BBNX0.00x

PRCT0.00x

P/B Ratio

BBNX3.99x

PRCT2.89x

P/FCF Ratio

BBNXN/A

PRCTN/A

EV/FCF

BBNX-12.19x

PRCT-10.26x

PEG Ratio

BBNXN/A

PRCTN/A

Forward P/E (NTM)

BBNXN/A

PRCTN/A

Forward P/S (NTM)

BBNX5.37x

PRCT2.35x

Revenue (TTM)

BBNX$119M

PRCT$337M

Revenue Growth (YoY)

BBNX94.1%

PRCT22.7%

Forward Rev Growth

BBNX34.2%

PRCT20.6%

Gross Margin (TTM)

BBNX58.3%

PRCT64.2%

Operating Margin (TTM)

BBNX0.0%

PRCT0.0%

EBITDA Margin (TTM)

BBNX-67.9%

PRCT-31.8%

Net Margin (TTM)

BBNX-61.3%

PRCT-32.5%

FCF Margin (TTM)

BBNX-51.6%

PRCT-25.2%

Net Income (TTM)

BBNX$-73M

PRCT$-110M

FCF (TTM)

BBNX$-61M

PRCT$-85M

EPS (TTM)

BBNX-$1.64

PRCT-$1.92

ROE (TTM)

BBNX-2630.0%

PRCT-3062.0%

ROA (TTM)

BBNX-2325.0%

PRCT-2211.0%

ROIC (TTM)

BBNX-2630.0%

PRCT-2676.0%

Cash

BBNX$44M

PRCT$228M

Debt

BBNX$0

PRCT$52M

Net Cash/Debt

BBNX$44M

PRCT$176M

Current Ratio (TTM)

BBNX8.88x

PRCT6.55x

Quick Ratio (TTM)

BBNX7.72x

PRCT5.23x

Debt/Equity (TTM)

BBNX0.00x

PRCT0.15x

Debt/Assets (TTM)

BBNX0.0%

PRCT0.0%

Interest Coverage (TTM)

BBNXN/A

PRCTN/A

Net Debt/EBITDA (TTM)

BBNX0.00x

PRCT0.00x

Beta

BBNX0.92

PRCT0.88

52W Performance

BBNX-20.3%

PRCT-47.1%

YTD Performance

BBNX-39.7%

PRCT-40.2%

% from 52W High

BBNX-46.1%

PRCT-51.7%

% from 52W Low

BBNX100.3%

PRCT10.4%

Asset Turnover (TTM)

BBNX0.38x

PRCT0.68x

FCF Yield (TTM)

BBNX-7.7%

PRCT-8.1%

Earnings Yield (TTM)

BBNX-9.2%

PRCT-10.5%

Dividend Yield (TTM)

BBNXN/A

PRCTN/A

Rule of 40

BBNX42.5

PRCT-2.5

EV/GP/RG

BBNX0.34

PRCT0.12

Ticker research

View BBNX research View PRCT research

Metric	BBNX Beta Bionics Inc	PRCT Procept Biorobotics Corp
Market & Valuation
Market Cap	$793M	$1.05B
Enterprise Value	$749M	$871M
Price	$17.63	$18.40
P/E Ratio	N/A	N/A
P/S Ratio	6.66x	3.10x
EV/Sales	6.29x	2.58x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.99x	2.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.19x	-10.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.37x	2.35x
Revenue & Growth
Revenue (TTM)	$119M	$337M
Revenue Growth (YoY)	94.1%	22.7%
Forward Rev Growth	34.2%	20.6%
Profitability
Gross Margin (TTM)	58.3%	64.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-67.9%	-31.8%
Net Margin (TTM)	-61.3%	-32.5%
FCF Margin (TTM)	-51.6%	-25.2%
Net Income (TTM)	$-73M	$-110M
FCF (TTM)	$-61M	$-85M
EPS (TTM)	-$1.64	-$1.92
ROE (TTM)	-2630.0%	-3062.0%
ROA (TTM)	-2325.0%	-2211.0%
ROIC (TTM)	-2630.0%	-2676.0%
Financial Health
Cash	$44M	$228M
Debt	$0	$52M
Net Cash/Debt	$44M	$176M
Current Ratio (TTM)	8.88x	6.55x
Quick Ratio (TTM)	7.72x	5.23x
Debt/Equity (TTM)	0.00x	0.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	0.88
52W Performance	-20.3%	-47.1%
YTD Performance	-39.7%	-40.2%
% from 52W High	-46.1%	-51.7%
% from 52W Low	100.3%	10.4%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.68x
FCF Yield (TTM)	-7.7%	-8.1%
Earnings Yield (TTM)	-9.2%	-10.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.5	-2.5
EV/GP/RG	0.34	0.12
Ticker research	View BBNX research	View PRCT research